id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-3902-0003,FDA,FDA-2024-N-3902,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-09-25T04:00:00Z,2025,9,,,2025-09-25T17:50:20Z,2025-18621,0,0,09000064b8fdc22d
FDA-2024-N-3902-0002,FDA,FDA-2024-N-3902,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution and Related Collections of Information,Notice,30 Day Proposed Information Collection,2024-12-20T05:00:00Z,2024,12,2024-12-20T05:00:00Z,2025-01-22T04:59:59Z,2024-12-20T14:17:07Z,2024-30355,0,0,09000064868815dc
FDA-2024-N-3902-0001,FDA,FDA-2024-N-3902,"Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of
Producers of Drugs and Listing of Drugs in Commercial Distribution and Related Collections of Information",Notice,60 Day Proposed Information Collection,2024-09-05T04:00:00Z,2024,9,2024-09-05T04:00:00Z,2024-11-05T04:59:59Z,2024-09-05T13:32:27Z,2024-19862,0,0,09000064866c2d0d